Clinical trial
Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute
NCT01938417 is registered in ClinicalTrials.gov with University of Lausanne Hospitals as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Tobramycin Exposure From Active Calcium Sulfate Bone Graft Substitute
- Lead sponsor
- University of Lausanne Hospitals
- Phase
- Observational
- Overall status
- Completed
- Start date
- October 31, 2006
- Completion date
- Not reported
- Enrollment
- 12 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.
orthopedic operations